Condensed Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 29, 2013	Jun. 30, 2012	Jun. 29, 2013	Jun. 30, 2012
Net sales	$ 1,403	$ 1,410	$ 2,741	$ 2,805
Cost of sales:
Cost of sales before special charges	381	367	740	725
Special charges	1	16	19	39
Total cost of sales	382	383	759	764
Gross Profit	1,021	1,027	1,982	2,041
Selling, general and administrative expense	489	494	957	984
Research and development expense	173	173	333	348
Special charges	77	22	102	69
Operating profit	282	338	590	640
Other expense, net	183	25	231	48
Earnings before noncontrolling interest and income taxes	99	313	359	592
Income tax expense (benefit)	(8)	69	30	136
Net earnings before noncontrolling interest	107	244	329	456
Net loss attributable to noncontrolling interest	(8)	0	(9)	0
Net earnings attributable to St. Jude Medical, Inc.	$ 115	$ 244	$ 338	$ 456
Net earnings per share attributable to St. Jude Medical, Inc.:
Basic	$ 0.41	$ 0.78	$ 1.19	$ 1.45
Diluted	$ 0.40	$ 0.78	$ 1.18	$ 1.44
Cash dividends declared per share:	$ 0.25	$ 0.23	$ 0.50	$ 0.46
Weighted average shares outstanding:
Basic	283.9	313.9	284.6	314.8
Diluted	286.7	315.2	287.1	316.4